WeVote
Log In

Bill

Bill

SF 1877

Pharmacy benefit managers and health carriers usage of prescription drug rebates and other compensation requirement to benefit covered persons provision

2025-2026 Regular Session Introduced by Alice Mann

Requires Minnesota pharmacy benefit managers and health carriers to pass prescription drug rebates directly to patients rather than keeping savings, lowering medication costs.

Comm report: To pass and re-referred to Commerce and Consumer Protection
#commerceandcommercedepartment #drugsandmedicine #insurance-health
0
WeVote Research Nonpartisan
Bill Summary · SF 1877

Legislative bill overview

SF 1877 requires pharmacy benefit managers (PBMs) and health carriers to pass prescription drug rebates and other compensation directly to covered persons, rather than retaining these funds. The bill mandates transparency in how rebates are applied and ensures patients benefit from negotiated drug price reductions.

Why is this important

Currently, PBMs often keep rebates negotiated with drug manufacturers while patients still pay high out-of-pocket costs. This bill directly addresses pharmaceutical affordability by requiring rebate savings reach consumers at the pharmacy counter, potentially lowering medication costs for insured Minnesotans.

Potential points of contention

  • Administrative burden: PBMs and insurers argue rebate pass-through complicates billing systems and increases operational costs, which could be passed to consumers
  • Market impact on drug pricing: Pharmaceutical manufacturers may adjust rebate strategies if savings must reach patients, potentially affecting overall drug pricing negotiations
  • Implementation complexity: Determining fair allocation of rebates across different insurance plans and patient populations creates technical and regulatory challenges

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.